These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 20482563)

  • 1. Initial liver graft function is a reliable predictor of tacrolimus trough levels during the first post-transplant week.
    Lock JF; Malinowski M; Schwabauer E; Martus P; Pratschke J; Seehofer D; Puhl G; Neuhaus P; Stockmann M
    Clin Transplant; 2011; 25(3):436-43. PubMed ID: 20482563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early diagnosis of primary nonfunction and indication for reoperation after liver transplantation.
    Lock JF; Schwabauer E; Martus P; Videv N; Pratschke J; Malinowski M; Neuhaus P; Stockmann M
    Liver Transpl; 2010 Feb; 16(2):172-80. PubMed ID: 20104485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients.
    Jain A; Venkataramanan R; Sharma R; Kwong T; Orloff M; Abt P; Kashyap R; Tsoulfas G; Batzold P; Williamson M; Bozorgzadeh A
    Transplantation; 2008 Feb; 85(4):554-60. PubMed ID: 18347534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic-pharmacodynamic assessment of tacrolimus in liver-transplant recipients during the early post-transplantation period.
    Blanchet B; Duvoux C; Costentin CE; Barrault C; Ghaleh B; Salvat A; Jouault H; Astier A; Tod M; Hulin A
    Ther Drug Monit; 2008 Aug; 30(4):412-8. PubMed ID: 18641556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of tacrolimus in rescue therapy after renal transplantation.
    Budde K; Fritsche L; Mai I; Bauer S; Smettan S; Waiser J; Hofmann T; Hauser I; Reinke P; Neumayer HH
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):493-7. PubMed ID: 8937932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
    Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
    Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation.
    Tanaka K; Lake J; Villamil F; Levy G; Marotta P; Mies S; de Hemptinne B; Moench C
    Liver Transpl; 2005 Nov; 11(11):1395-402. PubMed ID: 16237691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroids and living liver donation increase tacrolimus blood levels in living donor liver transplantation.
    Charco R; Rimola A; García-Valdecasas JC; Fuster J; Fondevila C; Navasa M; Julian M; Forta V; Brunet M
    Transplant Proc; 2005 Nov; 37(9):3930-1. PubMed ID: 16386588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential influence of tacrolimus and steroid avoidance on early graft function in pediatric renal transplantation.
    Li L; Weintraub L; Concepcion W; Martin JP; Miller K; Salvatierra O; Sarwal MM
    Pediatr Transplant; 2008 Sep; 12(6):701-7. PubMed ID: 18179640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal MDR1/ABCB1 level at surgery as a risk factor of acute cellular rejection in living-donor liver transplant patients.
    Masuda S; Goto M; Fukatsu S; Uesugi M; Ogura Y; Oike F; Kiuchi T; Takada Y; Tanaka K; Inui K
    Clin Pharmacol Ther; 2006 Jan; 79(1):90-102. PubMed ID: 16413244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of daclizumab as initial immunosuppression in liver transplant recipients with impaired renal function.
    Emre S; Gondolesi G; Polat K; Ben-Haim M; Artis T; Fishbein TM; Sheiner PA; Kim-Schluger L; Schwartz ME; Miller CM
    Liver Transpl; 2001 Mar; 7(3):220-5. PubMed ID: 11244163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance and prevalence of polymorphisms in CYP3A5 and MDR1 genes that encode tacrolimus biotransformation enzymes in liver transplant recipients.
    Barrera-Pulido L; Aguilera-García I; Docobo-Pérez F; Alamo-Martínez JM; Pareja-Ciuró F; Nuñez-Roldán A; Gómez-Bravo MA; Bernardos-Rodríguez A
    Transplant Proc; 2008 Nov; 40(9):2949-51. PubMed ID: 19010156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipients.
    Beckebaum S; Klein C; Varghese J; Sotiropoulos GC; Saner F; Schmitz K; Gerken G; Paul A; Cicinnati VR
    Aliment Pharmacol Ther; 2009 Oct; 30(8):834-42. PubMed ID: 19624550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to define initial poor graft function after liver transplantation? - a new functional definition by the LiMAx test.
    Stockmann M; Lock JF; Malinowski M; Seehofer D; Puhl G; Pratschke J; Neuhaus P
    Transpl Int; 2010 Oct; 23(10):1023-32. PubMed ID: 20444241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen.
    Irish W; Sherrill B; Brennan DC; Lowell J; Schnitzler M
    Transplantation; 2003 Dec; 76(12):1686-90. PubMed ID: 14688516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Efficacy and Safety of Tacrolimus in Pakistani Living Donor Liver Transplant Recipients.
    Azam F; Khan M; Bhatti ABH; Dar FS; Ahmad A; Javed N
    J Coll Physicians Surg Pak; 2019 Nov; 29(11):1048-1052. PubMed ID: 31659960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term graft function with tacrolimus and cyclosporine in renal transplantation: paired kidney analysis.
    Cheung CY; Chan HW; Liu YL; Chau KF; Li CS
    Nephrology (Carlton); 2009 Dec; 14(8):758-63. PubMed ID: 20025685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation.
    Staatz CE; Taylor PJ; Lynch SV; Tett SE
    Liver Transpl; 2004 Apr; 10(4):506-12. PubMed ID: 15048793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.